Cargando…
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients
Preclinical and clinical studies have suggested that cancer treatment with antitumor antibodies induces a specific adaptive T cell response. A central role in this process has been attributed to CD4(+) T cells, but the relevant T cell epitopes, mostly derived from non-mutated self-antigens, are larg...
Autores principales: | Milcent, Benoit, Josseaume, Nathalie, Riller, Quentin, Giglioli, Ilenia, Rabia, Emilia, Deligne, Claire, Latouche, Jean-Baptiste, Hamieh, Mohamad, Couture, Alexandre, Toutirais, Olivier, Lone, Yu-Chun, Jeger-Madiot, Raphaël, Graff-Dubois, Stéphanie, Amorim, Sandy, Loiseau, Pascale, Toubert, Antoine, Brice, Pauline, Thieblemont, Catherine, Teillaud, Jean-Luc, Sibéril, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805815/ https://www.ncbi.nlm.nih.gov/pubmed/31494742 http://dx.doi.org/10.1007/s00262-019-02389-7 |
Ejemplares similares
-
Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen
por: Milcent, B., et al.
Publicado: (2019) -
Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?
por: Deligne, Claire, et al.
Publicado: (2017) -
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy
por: Casadesús, Ana Victoria, et al.
Publicado: (2020) -
HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy
por: Couture, Alexandre, et al.
Publicado: (2019) -
The ADAMTS13(1239–1253) peptide is a dominant HLA-DR1-restricted CD4(+) T-cell epitope
por: Gilardin, Laurent, et al.
Publicado: (2017)